Press releases

Here you can find corporate releases on topics related to governance, investments, and important announcements.

Read more

Investors

Nasdaq:

CRMD

$ 11.2 Last update: 01/14/2025 7:47:35 pm ET Time Read more

About CRBSI

Learn more about Catheter-related blood stream infections (CRBSIs) and how they affect hemodialysis central venous catheter (HD-CVC) patients.

Read more
WHY CORMEDIX

We relentlessly pursue therapeutic options to reduce and treat infectious and inflammatory disease

About us
PRESS RELEASES

Review corporate releases related to governance,
investor news, and other important announcements.

Jan 07, 2025

CORMEDIX INC. ANNOUNCES PRELIMINARY FOURTH QUARTER 2024 RESULTS AND PROVIDES BUSINESS UPDATE
Dec 19, 2024

CORMEDIX INC. ADDED TO NASDAQ BIOTECHNOLOGY INDEX
Nov 26, 2024

CORMEDIX INC. SUPPORTS CMS POLICY UPDATES REGARDING ACCESS TO INNOVATIVE DRUG PRODUCTS
Nov 04, 2024

CORMEDIX INC. TO PARTICIPATE IN THE TRUIST SECURITIES BIOPHARMA SYMPOSIUM
Oct 30, 2024

CORMEDIX INC. REPORTS THIRD QUARTER AND NINE MONTH 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
See all